118 related articles for article (PubMed ID: 29277504)
1. SPARC is down-regulated by DNA methylation and functions as a tumor suppressor in T-cell lymphoma.
Yan J; Zhang J; Zhang X; Li X; Li L; Li Z; Chen R; Zhang L; Wu J; Wang X; Sun Z; Fu X; Chang Y; Nan F; Yu H; Wu X; Feng X; Li W; Zhang M
Exp Cell Res; 2018 Mar; 364(2):125-132. PubMed ID: 29277504
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.
Shao S; Zhou NM; Dai DQ
World J Gastroenterol; 2019 Dec; 25(46):6713-6727. PubMed ID: 31857774
[TBL] [Abstract][Full Text] [Related]
3. Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer.
Li XL; Li JL; Qiu DJ; Ma L
Neoplasma; 2022 Jul; 69(4):794-806. PubMed ID: 35400166
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter methylation of SPARC in ovarian cancer.
Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
[TBL] [Abstract][Full Text] [Related]
5. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
[TBL] [Abstract][Full Text] [Related]
7. Potential Prognostic Role of
Fabrizio FP; Sparaneo A; Fontana A; Mazza T; Graziano P; Pantalone A; Parente P; Centra F; Orlando N; Trombetta D; Torre A; Ferretti GM; Taurchini M; Micco CMD; Maiello E; Fazio VM; Rossi A; Muscarella LA
Cells; 2020 Jun; 9(6):. PubMed ID: 32580473
[TBL] [Abstract][Full Text] [Related]
8. Inhibitor of DNA binding 4 functions as a tumor suppressor and is targetable by 5-aza-2'-deoxycytosine with potential therapeutic significance in Burkitt's lymphoma.
Gao XZ; Zhao WG; Wang GN; Cui MY; Zhang YR; Li WC
Mol Med Rep; 2016 Feb; 13(2):1269-74. PubMed ID: 26648013
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.
Zhang Y; Yang B; Du Z; Bai T; Gao YT; Wang YJ; Lou C; Wang FM; Bai Y
World J Gastroenterol; 2012 May; 18(17):2043-52. PubMed ID: 22563191
[TBL] [Abstract][Full Text] [Related]
10. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract][Full Text] [Related]
11. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
13. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
[TBL] [Abstract][Full Text] [Related]
14. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
16. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
[TBL] [Abstract][Full Text] [Related]
17. AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma.
Yan J; Zhang J; Zhang X; Li X; Li L; Li Z; Chen R; Zhang L; Wu J; Wang X; Sun Z; Fu X; Chang Y; Nan F; Yu H; Wu X; Feng X; Li W; Zhang M
Mol Med; 2018 Jul; 24(1):35. PubMed ID: 30134829
[TBL] [Abstract][Full Text] [Related]
18. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
19. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
[TBL] [Abstract][Full Text] [Related]
20. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
